Amrize Ltd (AMRZ) EBITDA
- 2026-06-30: Basis Reported; EBITDA $928M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA $126M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $678M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $970M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $928M | (m) | (m) | (m) | 26.56% | $245.00M* | $418.00M* | $2.50B | (m) | $283.00M | $146.00M |
|---|
| 2026-03-31 | Reported | $126M | (m) | (m) | (m) | 5.78% | $275.00M | -$893.00M | $1.97B | (m) | $285.00M | -$41.00M |
|---|
| 2025-12-31 | Reported | $678M | (m) | (m) | (m) | 23.88% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $970M | (m) | (m) | (m) | 26.39% | $183.00M* | $845.00M* | $2.59B | (m) | $312.00M | $150.00M |
|---|
| 2025-06-30 | Reported | $844M | (m) | (m) | (m) | 26.23% | $235.00M* | $406.00M* | $2.28B | (m) | $286.00M | $122.00M |
|---|
| 2025-03-31 | Reported | $176M | (m) | (m) | (m) | 8.43% | $213.00M | -$847.00M | $1.85B | (m) | $243.00M | -$28.00M |
|---|
| 2024-12-31 | Reported | $731M | (m) | (m) | (m) | 25.66% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $1.03B | (m) | (m) | (m) | 29.98% | $221.00M* | $623.00M* | $2.40B | (m) | $241.00M | $155.00M |
|---|
| 2024-06-30 | Reported | $936M | (m) | (m) | (m) | 28.86% | (m) | (m) | $2.26B | (m) | $228.00M | $149.00M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $2.66B | (m) | (m) | (m) | 22.55% | $788.00M | $2.21B | $8.78B | (m) | $1.13B | $326.00M |
|---|
| 2024-12-31 | Reported | $2.93B | (m) | (m) | (m) | 25.04% | $642.00M | $2.28B | $8.63B | (m) | $944.00M | $368.00M |
|---|
| 2023-12-31 | Reported | $2.58B | (m) | (m) | (m) | 22.07% | $630.00M | $2.04B | $8.91B | (m) | $898.00M | $361.00M |
|---|